Droguerie Phenicia

What Droguerie Phenicia does

Droguerie Phenicia is a privately held Lebanese pharmaceutical distribution company founded in 1967 by Michel Salim Halabi and headquartered in Antelias, Lebanon. Operating under the trade name Phenicia Group, the company functions as an authorized medicines intermediary, importing and distributing pharmaceutical products on behalf of 15+ international manufacturers across nine therapeutic areas—gastroenterology, cardiology and vascular disease, neurology and psychiatry, respiratory and allergy, antimicrobials, pain and inflammation, hematology, endocrinology, and urinary tract/lithiasis. Its portfolio comprises 95+ active branded generic and specialty products sourced from principals including Gador SA (Argentina), Alfasigma and Italfarmaco (Italy), Almirall and Normon (Spain), Acino (France), BIOSIDUS, Elea Phoenix, Roemmers (Argentina), KVK Tech (United States), and Korea United Pharm.

The company's core technology and capability is regulatory and supply-chain intermediation rather than software: it holds Lebanese Ministry of Health Registration number 87/1 and operates a licensed named-patient import channel for medicines not locally approved, exemplified by Trixacar (elexacaftor/tezacaftor/ivacaftor), a cystic fibrosis CFTR modulator distributed on behalf of Gador SA. Distribution flows through three channels—direct sales to 3,250+ local healthcare providers (hospitals, clinics, pharmacies), pharmacy and retail reseller networks, and direct-to-consumer named-patient fulfillment with individual quotation and import logistics. Pricing for specialty products is quote-based, incorporating manufacturer cost, Lebanese Order of Physicians/Pharmacists regulatory fees, shipping, and separately assessed import taxes.

Revenue is generated through two streams: pharmaceutical product distribution across the broad therapeutic portfolio, and transaction-fee based named-patient import services for specialty medicines. The company markets primarily through healthcare-professional networks, medical-education content, and disease-awareness campaigns rather than consumer advertising. Ownership appears to remain with the founding family, with no disclosed institutional investors, parent company, funding rounds, or M&A activity in the input data; legal entity is a private Lebanese limited company with no public ticker.

Name

Droguerie Phenicia

Legal name

Droguerie Phenicia

Website

https://pheniciagroup.com

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

51–100 employees

Short description

Droguerie Phenicia is a privately held Lebanese pharmaceutical distributor founded in 1967 that imports and markets 95+ products across 9 therapeutic areas on behalf of 15+ international manufacturers, serving 3,250+ healthcare providers and operating a licensed named-patient import program for specialty medicines such as Trixacar.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Specialty Care Pharmaceuticals (HLAIAAAB), Pharmaceutical & Biologics Courier (Rx, Specialty Drugs) (TLAAAIAB)

Keywords

• Pharmaceutical distribution
• Pharmaceutical importation
• Specialty medicine supply
• Branded generic medications
• Named patient imports

Headquarters

HQ city

Anntelias

HQ country

Lebanon

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Others

Revenue model

1. Pharmaceutical Product Distribution: Droguerie Phenicia distributes pharmaceutical products from international manufacturing partners across the Lebanese market. Revenue is generated through the sale of medications across multiple therapeutic areas including gastroenterology, cardiology, neurology, and others.
2. Named Patient Import Services: For specialty medicines not locally approved (e.g., Trixacar), the company imports medicines on behalf of individual patients. Patients place orders with required documentation (prescription, ID), and the company sources and delivers medications internationally. Pricing includes manufacturer base cost, Lebanese regulatory fees, shipping, and applicable taxes.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Droguerie Phenicia is a Lebanese pharmaceutical importer and distributor that markets and distributes a portfolio of 95+ branded generic and specialty medicines from 15+ international manufacturers across 9 therapeutic areas. The company also operates a named patient import program that sources and delivers medicines not locally approved (such as Trixacar for cystic fibrosis) directly to patients on prescription.

Product overview

Droguerie Phenicia is a Lebanese pharmaceutical company distributing a broad portfolio of over 95 branded generic medications across multiple therapeutic areas including Cardiology and Vascular disease (BLOKIUM, LIPONORM, LIPONORM PLUS, SINLIP, SIMVASTATIN NORMON, BISOPROLOL NORMON, NORMOPRIL, HEPERONA, SEGUREX, VESSEL DUE F), Neurology and Psychiatry (ESCITALOPRAM NORMON, LAMOTRIGINE NORMON, INDUCTAL, PLENICA, BLASTOFERON), Gastroenterology (NORMIX, ESOMEPRAZOLE NORMON, GASTRIMUT, SPASFON, CINITREX, MOSAR, MOSAR PLUS, DANLOX, CARIBAN, RABEC, FamoNor, NEWBUTIN), Respiratory and Allergy (EBASTEL, ESLORAT, FRENALER CORT, RINISONA), Antimicrobials (LEFLUMAX, ESTECINA, FIXIM, LEVOFLOXACIN NORMON, FARMODOXI, IFENEC, MITONCO, OVUMIX), Pain and Inflammation (AIRTAL, DIFEN family, DORIXINA family, NORMOCOXIB, NORMODEX, NORFEN, ParaNor, VitaNor), Hematology (HEMAX, NEUTROMAX, FERPLEX, HEPAXANE), Endocrinology (ADROMUX, MARVIL, ORAVIL, HHT, OSTEOFORTIL), and Urinary Tract (UROKIT). Additionally, they serve as the official agent for Trixacar (elexacaftor/tezacaftor/ivacaftor), a cystic fibrosis treatment manufactured by Gador SA.

Differentiator

Problem solved

Functional benefit

Products and services

• Trixacar Elexacaftor/tezacaftor/ivacaftor triple-combination CFTR modulator distributed by Droguerie Phenicia as the official agent for Gador SA in Lebanon; supplied to cystic fibrosis patients with F508del mutation through a named patient import program.
• ADROMUX Ibandronate monosodium monohydrate tablet indicated for treatment and prevention of osteoporosis in postmenopausal women.
• AIRTAL DIFUCREM 1.5% Topical aceclofenac cream for local treatment of inflammatory and painful musculoskeletal conditions including traumatisms and acute or chronic musculoskeletal inflammation.
• AIRTAL Tablets Aceclofenac 100mg NSAID tablets for treatment of painful and chronic inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.
• BISOPROLOL NORMON Bisoprolol beta-blocker for treatment of arterial hypertension and stable chronic angina pectoris.
• BLASTOFERON Interferon beta 1a (22 μg and 44 μg) injection for chronic treatment of multiple sclerosis.
• BLOKIUM Atenolol beta-blocker (50mg and 100mg) for treatment of essential hypertension, angina pectoris, and cardiac arrhythmias.
• CARIBAN Doxylamine succinate and pyridoxine hydrochloride combination for symptomatic treatment of nausea and vomiting during pregnancy.
• CINITREX Cinitapride prokinetic for treatment of nausea, gastroesophageal reflux, and mild-to-moderate functional gastrointestinal motility disorders.
• DANLOX QUICK Omeprazole and sodium bicarbonate combination for relief of heartburn, excess stomach acid, and ulcer treatment with quick and long-lasting effect.
• DIFEN B12 Cyanocobalamin, diclofenac potassium, and betamethasone combination for symptomatic treatment of acute inflammatory processes with neurotic and musculoskeletal components.
• DIFEN FLEX Sodium diclofenac and pridinol mesylate combination for painful inflammatory processes with muscular contracture.
• DIFEN GESIC Paracetamol and diclofenac potassium combination tablet for fever control and acute pain relief with anti-inflammatory effect.
• DIFEN PLUS Diclofenac potassium and betamethasone combination for symptomatic treatment of renal colic and musculoskeletal acute inflammatory processes.
• DILOCAIN 2% Lidocaine 2% with epinephrine injection for local anesthesia.
• DORIXINA Lysine clonixinate analgesic for treatment of somatic or visceral pain.
• DORIXINA B1 B6 B12 Lysine clonixinate with B vitamins combination for symptomatic treatment of musculoskeletal acute inflammatory processes with neuritic component.
• DORIXINA RELAX Lysine clonixinate and cyclobenzaprine combination for treatment of musculoskeletal pain especially with muscle spasms.
• EBASTEL Ebastine antihistamine for symptomatic treatment of allergic conditions including allergic rhinitis and conjunctivitis.
• ESCITALOPRAM NORMON Escitalopram SSRI antidepressant for treatment of depression and related diseases affecting the brain serotonergic system.
• ESLORAT Desloratadine for relief of allergic rhinitis and urticaria symptoms.
• ESOMEPRAZOLE NORMON Esomeprazole injection for short-term treatment of gastroesophageal reflux disease and prevention of gastric ulcers associated with NSAIDs.
• ESTECINA Injection Ciprofloxacin lactate injectable antibiotic for treatment of infections caused by susceptible Gram-positive and Gram-negative organisms.
• ESTECINA Tablets Ciprofloxacin oral broad-spectrum antibacterial agent for treatment of respiratory, skin, bone, joint, and urinary tract infections.
• FamoNor Famotidine H2-blocker for treatment of duodenal and gastric ulcers, GERD, and Zollinger-Ellison syndrome.
• FARMODOXI Doxycycline hyclate antibiotic for infections caused by susceptible Gram-positive and Gram-negative germs.
• FERPLEX Iron protein succinylate antianemic for treatment of iron deficiency and iron deficiency anemia.
• FIXIM Cefixime cephalosporin antibiotic for treatment of infectious processes including sinusitis, pharyngitis, bronchitis, and urinary tract infections.
• FRENALER CORT Desloratadine and betamethasone combination for treatment of severe allergic conditions requiring antihistamine and systemic corticosteroid therapy.
• GASTRIMUT Omeprazole proton pump inhibitor for prevention of gastric acid secretion.
• HEMAX Recombinant human erythropoietin (4000, 10000, 40000 IU) erythropoiesis stimulant.
• HEPAXANE Enoxaparin sodium low molecular weight heparin for treatment and prevention of blood clots.
• HHT Somatropin growth hormone (4 IU and 16 IU) for treatment of growth hormone deficiency.
• IFENEC Econazole nitrate vaginal antifungal for mycotic vulvo-vaginal infections.
• INDUCTAL Eszopiclone sedative for treatment of insomnia to improve sleep latency and maintenance.
• LAMOTRIGINE NORMON Lamotrigine antiepileptic for treatment of different types of epilepsy and bipolar disorder.
• LEFLUMAX Levofloxacin fluoroquinolone antibiotic (500mg and 750mg) for respiratory and urinary tract infections.
• LEVOFLOXACIN NORMON Levofloxacin injectable antibiotic for community-acquired pneumonia, complicated urinary tract infections, and skin infections.
• LIPONORM Atorvastatin HMG-CoA reductase inhibitor for treatment of hypercholesterolemia and cardiovascular risk reduction.
• LIPONORM PLUS Atorvastatin and ezetimibe combination for reduction of elevated total cholesterol and LDL in patients with hypercholesterolemia.
• MARVIL Alendronate bisphosphonate (70mg) for treatment of osteoporosis in postmenopausal women and men.
• MITONCO Mitomycin 10mg injection for treatment of bladder, gastric, colon, rectal, and lung cancers.
• MOSAR PLUS Mosapride citrate and simethicone combination for enhanced gastric emptying and digestive motility modulation.
• MOSAR Mosapride citrate for treatment of non-ulcer dyspepsia, GI symptoms, and reflux esophagitis.
• NEUTROMAX Filgrastim (r-met-hu-G-CSF) for increase of neutrophil count in peripheral blood.
• NEWBUTIN SR Trimebutine maleate sustained-release formulation for regulation of abnormal gastrointestinal motility and IBS symptoms.
• NORFEN Ibuprofen NSAID (400mg) for reduction of inflammation, pain, and fever.
• NORMIX Rifaximine antibiotic (200mg tablets and suspension) for acute and chronic intestinal infections and diarrhea.
• NORMOCOXIB Celecoxib COX-2 inhibitor NSAID for relief of pain and swelling in arthritis and acute pain.
• NORMODEX Dexketoprofen NSAID (25mg) for fast pain relief from mild to moderate pain.
• NORMOPRIL Ramipril ACE inhibitor (2.5mg, 5mg, 10mg) for treatment of hypertension and cardiovascular risk reduction.
• ORAVIL Cholecalciferol (Vitamin D3) 100,000 IU for prevention and treatment of vitamin D deficiency.
• OSTEOFORTIL Teriparatide osteoanabolic agent for treatment of severe osteoporosis and fracture prevention.
• OVUMIX Metronidazole, miconazole, neomycin, and polymyxin vaginal suppository for local treatment of vulvovaginitis.
• ParaNor Paracetamol analgesic (650mg) for mild-to-moderate pain and fever.
• PLENICA Pregabalin (25mg, 75mg, 150mg) for treatment of partial onset seizures, neuropathic pain, anxiety, and fibromyalgia.
• RABEC Rabeprazole sodium proton pump inhibitor for treatment of duodenal and gastric ulcers, GERD, and H. pylori eradication.
• RINISONA Fluticasone propionate nasal spray for treatment and prophylaxis of seasonal and perennial allergic rhinitis.
• SEGUREX Sildenafil citrate for oral treatment of erectile dysfunction in men.
• SIMVASTATIN NORMON Simvastatin HMG-CoA reductase inhibitor (10mg, 20mg, 40mg) for reduction of LDL cholesterol and triglycerides.
• SINLIP Rosuvastatin calcium statin (5mg, 10mg, 20mg) for treatment of primary hypercholesterolemia and mixed dyslipidemia.
• SPASFON Phloroglucinol and trimethylphloroglucinol antispasmodic for treatment of spasmodic pain from intestine, biliary tract, bladder, and uterus.
• UROKIT Potassium citrate monodose for treatment and prevention of renal lithiasis.
• VESSEL DUE F Capsules Sulodexide glycosaminoglycan (250 LSU) with antithrombotic action for arterial and venous systems.
• VitaNor Vitamin B complex supplement (thiamine, pyridoxine, cyanocobalamin) for nerve health and neuropathy support.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered core and standard.

• Gador S.A - ArgentinacoreStrategic or Co-development PartnerGador S.A is an Argentine pharmaceutical company with outstanding prescription market position. Droguerie Phenicia is the official agent for Gador SA in Lebanon, distributing specialty products including Trixacar (elexacaftor/tezacaftor/ivacaftor) for cystic fibrosis treatment.
• Alfa Sigma S.P.A - ItalycoreStrategic or Co-development PartnerAlfasigma is a major Italian pharmaceutical group created in 2015 by aggregating Alfa Wassermann and Sigma-Tau. One of Italy's top pharmaceutical companies focused on improving health and quality of life for aging populations.
• Almirall S.A. - SpaincoreStrategic or Co-development PartnerA global, research-focused biopharmaceutical company based in Barcelona, Spain, founded 75 years ago.
• BIOSIDUS S.A - ArgentinacoreStrategic or Co-development PartnerAn Argentina-based company with impressive track record in development, manufacture and supply of top quality biosimilars commercially available across four continents through a vast network of licensees.
• Casasco S.A.I.C. - ArgentinastandardStrategic or Co-development PartnerLaboratorios Casasco S.A.I.C. products have achieved prestige through GMP standards, high quality standards, optimized processes and commitment to environment.
• Dr Lazar y Cia. S.A.Q. e.I - ArgentinastandardStrategic or Co-development PartnerArgentine pharmaceutical company partner.
• Acino France SAS - FrancecoreStrategic or Co-development PartnerSwiss-headquartered pharmaceutical company Acino's French operation, focused on delivering innovative healthcare solutions.
• ITALFARMACO S.p.A. - ItalycoreStrategic or Co-development PartnerA private multinational group founded in 1938 and based in Milan, Italy. Committed to improving patients' lives through pioneering research and development, high-quality production, and global marketing of branded prescription and non-prescription products.
• KOREA UNITED PHARM.INC. - KoreastandardStrategic or Co-development PartnerKorean owned multinational pharmaceutical company established in 1987 with goals of spreading health and happiness worldwide.
• KVK TECH - United StatesstandardStrategic or Co-development PartnerA leader in development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs.
• LABORATORIO ELEA PHOENIX S.A. - ArgentinacoreStrategic or Co-development PartnerElea has been developing products, medications and treatments for every medical specialty for over 80 years, accompanying patients throughout their lives.
• Normon S.A. - SpaincoreStrategic or Co-development PartnerFounded in 1937, Normon celebrates over 80 years of commitment to Spanish society, manufacturing high quality medicinal products. Pioneer in generic drugs in Spain.
• Roemmers S.A.I.C.F. - ArgentinacoreStrategic or Co-development PartnerLaboratorios Roemmers produces a wide range of medicines for important therapeutic lines. Leader in cardiology, pediatrics, clinical practice, geriatrics and surgery products.
• Versalya Pharma S.L (Italfarmaco Group) - ItalystandardStrategic or Co-development PartnerVersalya Pharma products are manufactured in Europe to highest international quality standards. Wide range comprises pharmaceutical products, food supplements, cosmetic products and medical devices.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Cipla: India-based global pharmaceutical company with strong presence in emerging markets distributing branded generics across respiratory, cardiology, and other therapeutic areas. Comparable as an emerging-markets pharmaceutical distributor serving similar therapy categories and provider channels.
• Aurobindo Pharma: India-headquartered global pharmaceutical company distributing generics and specialty products worldwide including emerging markets. Comparable in distributing broad generic portfolios across multiple therapy areas, though at significantly larger scale and broader geographic footprint.
• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer and distributor serving MENA markets with generics, biosimilars, and consumer health. Comparable as a regional pharma distributor covering overlapping therapy areas, but operating at larger scale and broader geographic scope.
• Hikma Pharmaceuticals: Jordan-headquartered multinational pharmaceutical company with major branded generics, injectables, and biosimilars franchise across MENA and the US. Comparable as a larger MENA pharma distributor serving similar therapeutic categories, though far broader in scale and geographies.

Direct peers

• Mephico SAL: Lebanese pharmaceutical manufacturer and distributor with broad generic portfolio. Operates in the same Lebanese market with overlapping therapy areas and similar agency/distribution model serving hospitals and pharmacies.
• Algorithm S.A.L. Lebanon-based pharmaceutical marketing and distribution company with international manufacturer agency relationships, distributing branded pharmaceuticals to Lebanese healthcare providers. Direct competitor in the same Beirut-anchored distributor category.
• Benta Pharma Industries: Lebanese pharmaceutical manufacturer and distributor with branded generics and specialty portfolio across MENA. Comparable as a Lebanon-anchored pharma company operating similar therapy areas and distribution to local providers, though Benta also has manufacturing.
• Pharmaline SAL: Lebanese pharmaceutical company manufacturing and distributing generic and branded medicines. Comparable as a Lebanon-based pharma operator with similar portfolio breadth and provider distribution focus.

Others

• Acino Pharma: Swiss-headquartered specialty pharmaceutical company focused on emerging markets with branded generics and specialty portfolio. Listed as a current partner of Droguerie Phenicia, comparable as a manufacturer-side counterpart whose products Droguerie Phenicia distributes in Lebanon.

Regional players

• Tabuk Pharmaceuticals: Saudi Arabia-based pharmaceutical company manufacturing and marketing branded generics across MENA. Comparable in business model (international partner agencies, branded generics portfolio) though primarily serving Saudi and Gulf markets rather than Lebanon.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Droguerie Phenicia